E Fuller Torrey1. 1. Stanley Medical Research Institute and Department of Psychiatry, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20815, USA. torreyf@stanleyresearch.org
Abstract
OBJECTIVES: To assess the incidence of prostate cancer in individuals with schizophrenia. METHODS: A MEDLINE search was performed for all studies of "prostate cancer" or "cancer" and "schizophrenia." RESULTS: Five studies had age-standardized, site-specific cancer data. All five had a lower standardized incidence ratio for prostate cancer, ranging from 0.49 to 0.76. The incidence of cancer at other sites varied among the studies. Possible explanations included ascertainment bias; genetic factors; antipsychotic drug effects, either by being cancer protective or decreasing testosterone, or both; and lifestyle differences, such as prolonged hospitalization resulting in a decreased opportunity for heterosexual intercourse. CONCLUSIONS: The results of this study have revealed that the incidence of prostate cancer in individuals with schizophrenia is significantly lower than expected.
OBJECTIVES: To assess the incidence of prostate cancer in individuals with schizophrenia. METHODS: A MEDLINE search was performed for all studies of "prostate cancer" or "cancer" and "schizophrenia." RESULTS: Five studies had age-standardized, site-specific cancer data. All five had a lower standardized incidence ratio for prostate cancer, ranging from 0.49 to 0.76. The incidence of cancer at other sites varied among the studies. Possible explanations included ascertainment bias; genetic factors; antipsychotic drug effects, either by being cancer protective or decreasing testosterone, or both; and lifestyle differences, such as prolonged hospitalization resulting in a decreased opportunity for heterosexual intercourse. CONCLUSIONS: The results of this study have revealed that the incidence of prostate cancer in individuals with schizophrenia is significantly lower than expected.
Authors: Irina N Bespalova; Gary W Angelo; Ben P Ritter; Jason Hunter; Maria L Reyes-Rabanillo; Larry J Siever; Jeremy M Silverman Journal: Neuromolecular Med Date: 2012-02-10 Impact factor: 3.843
Authors: Irina N Bespalova; Martina Durner; Benjamin P Ritter; Gary W Angelo; Enrique Rossy-Fullana; Jose Carrion-Baralt; James Schmeidler; Jeremy M Silverman Journal: Schizophr Res Date: 2010-09-26 Impact factor: 4.939
Authors: Lara C Weinstein; Ana Stefancic; Amy T Cunningham; Katelyn E Hurley; Leopodo J Cabassa; Richard C Wender Journal: CA Cancer J Clin Date: 2015-12-10 Impact factor: 508.702
Authors: Matthew T O'Brien; Jonathan S Oakhill; Naomi X Y Ling; Christopher G Langendorf; Ashfaqul Hoque; Toby A Dite; Anthony R Means; Bruce E Kemp; John W Scott Journal: Sci Rep Date: 2017-02-23 Impact factor: 4.379